rs754882266
Variant summary
Our verdict is Pathogenic. The variant received 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_199242.3(UNC13D):c.1727+1G>A variant causes a splice donor, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000616 in 1,460,910 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_199242.3 splice_donor, intron
Scores
Clinical Significance
Conservation
Publications
- familial hemophagocytic lymphohistiocytosis 3Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Laboratory for Molecular Medicine, Ambry Genetics, Labcorp Genetics (formerly Invitae), ClinGen
- hereditary hemophagocytic lymphohistiocytosisInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 18 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| UNC13D | NM_199242.3 | c.1727+1G>A | splice_donor_variant, intron_variant | Intron 19 of 31 | ENST00000207549.9 | NP_954712.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| UNC13D | ENST00000207549.9 | c.1727+1G>A | splice_donor_variant, intron_variant | Intron 19 of 31 | 1 | NM_199242.3 | ENSP00000207549.3 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD2 exomes AF: 0.00000801 AC: 2AN: 249818 AF XY: 0.0000148 show subpopulations
GnomAD4 exome AF: 0.00000616 AC: 9AN: 1460910Hom.: 0 Cov.: 35 AF XY: 0.0000124 AC XY: 9AN XY: 726720 show subpopulations
Age Distribution
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Familial hemophagocytic lymphohistiocytosis 3 Pathogenic:3
This sequence change affects a donor splice site in intron 19 of the UNC13D gene. It is expected to disrupt RNA splicing. Variants that disrupt the donor or acceptor splice site typically lead to a loss of protein function (PMID: 16199547), and loss-of-function variants in UNC13D are known to be pathogenic (PMID: 14622600). This variant is present in population databases (rs754882266, gnomAD 0.006%). This variant has not been reported in the literature in individuals affected with UNC13D-related conditions. ClinVar contains an entry for this variant (Variation ID: 533098). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic.
The splice site c.1727+1G>A variant has not been reported previously as a pathogenic variant nor as a benign variant, to our knowledge. The c.1727+1G>A variant is novel (not in any individuals) in 1000 Genomes and has an allele frequency of 0.0008% in gnomAD database. This variant has been reported to the ClinVar database as Likely Pathogenic. Loss of function variants have been previously reported to be disease causing. For these reasons, this variant has been classified as Likely Pathogenic. No significant variant in UNC13D gene has been observed in the spouse.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at